1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Non-squamous, Non-Small-Cell Lung Cancer: new trials by email Literature Review of Non-squamous, Non-Small-Cell Lung Cancer trials Research Report on Non-squamous, Non-Small-Cell Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours BI 836880, Ezabenlimab - Non-squamous, Non-Small-Cell Lung Cancer, Neoplasms | Phase 1 | Completed | Boehringer Ingelheim | 252 | 2018-07-05 | 2025-11-10 |
Carcinoma, Non-Small-Cell Lung (1) · Neoplasms (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Australia (1) · France (1) · Germany (1) · Hong Kong (1) · Poland (1) · Russia (1) · South Korea (1) · Spain (1) · Taiwan (1) · Ukraine (1) · United Kingdom (1) · United States (1)
2017 (1)